4

OWNERSHIP DOCUMENT

Company: Tonix Pharmaceuticals Holding Corp.
Filed: March 23, 2016
Period of Report: March 23, 2016
Accession Number: 0001144204-16-089880

View Document ↗ View on SEC.gov ↗